DeCode to Accelerate Existing-Product Marketing to MDs, Advance New Tests | GenomeWeb
In the coming months, DeCode Genetics plans to intensify its strategy of marketing its tests to US doctors, a demographic the Icelandic company believes will be the bread and butter of its diagnostics business.
 
Presenting the company’s research and development efforts to investors last week, DeCode officials explained that the company will employ an amalgam of commercialization strategies rather than focus on a single marketing approach, specifically direct-to-consumer advertising.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.